Date
19 October 2017

NDRC sets price-caps on 142 basic drugs in Shanghai, paper says

The Shanghai bureau of the National Development and Reform Commission (NDRC) announced Monday retail price ceilings for 142 basic drugs, the China Securities Journal reported Monday. The new restrictions took effect in the city on Tuesday. The policies will affect 25 drug products from fifteen A-share listed firms, including Zhejiang Jingxin Pharmaceutical Co. Ltd. (002020.CN), Jiangsu Nhwa Pharmaceutical Co. Ltd. (002262.CN) and Zhejiang Huahai Pharmaceutical Co. Ltd. (600521.CN).

– Contact HKEJ at [email protected]

EL/AC/RC

 

EJI Weekly Newsletter

Please click here to unsubscribe